Comparison of Resolute Zotarolimus-Eluting Stents and Sirolimus-Eluting Stents in Patients With De Novo Long Coronary Artery Lesions A Randomized LONG-DES IV Trial

Title
Comparison of Resolute Zotarolimus-Eluting Stents and Sirolimus-Eluting Stents in Patients With De Novo Long Coronary Artery Lesions A Randomized LONG-DES IV Trial
Author(s)
박종선안정민[안정민]박덕우[박덕우]김영학[김영학]송해근[송해근]조영락[조영락]김원장[김원장]이종영[이종영]강수진[강수진]이승환[이승환]이철환[이철환]박성욱[박성욱]윤승철[윤승철]한승봉[한승봉]이성윤[이성윤]이봉기[이봉기]조장현[조장현]양태현[양태현]이내희[이내희]양주영[양주영]신원용[신원용]김무현[김무현]배장호[배장호]김명곤[김명곤]윤정한[윤정한]박승정[박승정]
Keywords
IMPLANTATION; RESTENOSIS; DISEASE; SYSTEM; REVASCULARIZATION; INTERVENTION; THROMBOSIS; EFFICACY; OUTCOMES
Issue Date
201210
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Citation
CIRCULATION-CARDIOVASCULAR INTERVENTIONS, v.5, no.5, pp.633 - 640
Abstract
Background-Procedural and clinical outcomes still remain unfavorable for patients with long coronary lesions who undergo stent-based coronary interventions. Therefore, we compared the relative efficacy and safety of resolute zotarolimus-eluting stents (R-ZES) and sirolimus-eluting stents (SES) for patients with de novo long coronary lesions. Methods and Results-This randomized, multicenter, prospective trial, called the Percutaneous Treatment of LONG Native Coronary Lesions With Drug-Eluting Stent-IV (LONG-DES IV) trial, compared long R-ZES and SES in 500 patients with long (>= 25 mm) native coronary lesions. The primary end point of the trial was in-segment late luminal loss at 9-month angiographic follow-up. The baseline characteristics were not different between R-ZES and SES groups, including lesion lengths (32.4 +/- 13.5 mm versus 31.0 +/- 13.5 mm, P=0.27). At 9-month angiographic follow-up, the R-ZES was noninferior to the SES with respect to in-segment late luminal loss, the primary study end point (0.14 +/- 0.38 mm versus 0.12 +/- 0.43 mm, P for noninferiority=0.03, P for superiority=0.68). In addition, in-stent late luminal loss (0.26 +/- 0.36 mm versus 0.24 +/- 0.42 mm, P=0.78) and the rates of in-segment (5.2% versus 7.2%, P=0.44) and in-stent (4.0% versus 6.0%, P=0.41) binary restenosis were not significantly different between the 2 groups. There were no significant between-group differences in the rate of adverse clinical events (death, myocardial infarction, stent thrombosis, target-lesion revascularization, and composite outcomes). Conclusions-For patients with de novo long coronary artery disease, R-ZES implantation showed noninferior angiographic outcomes as compared with SES implantation.
URI
http://hdl.handle.net/YU.REPOSITORY/27085http://dx.doi.org/10.1161/CIRCINTERVENTIONS.111.965673
ISSN
1941-7640
Appears in Collections:
의과대학 > 내과학교실 > Articles
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE